pramipexol retard sandoz 2.1 mg compr. lib. prol.
sandoz sa-nv - dichlorhydrate de pramipexole monohydraté 3 mg - eq. pramipexole 2,1 mg - comprimé à libération prolongée - 2,1 mg - dichlorhydrate de pramipexole monohydraté 3 mg - pramipexole
pramipexol retard sandoz 3.15 mg compr. lib. prol.
sandoz sa-nv - dichlorhydrate de pramipexole monohydraté 4,5 mg - eq. pramipexole 3,15 mg - comprimé à libération prolongée - 3,15 mg - dichlorhydrate de pramipexole monohydraté 4.5 mg - pramipexole
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - agents antinéoplasiques - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
apo-pramipexole comprimé
apotex inc - dichlorhydrate de pramipexole monohydraté - comprimé - 0.25mg - dichlorhydrate de pramipexole monohydraté 0.25mg - nonergot-derivative dopamine receptor agonists
apo-pramipexole comprimé
apotex inc - dichlorhydrate de pramipexole monohydraté - comprimé - 0.5mg - dichlorhydrate de pramipexole monohydraté 0.5mg - nonergot-derivative dopamine receptor agonists
apo-pramipexole comprimé
apotex inc - dichlorhydrate de pramipexole monohydraté - comprimé - 1.0mg - dichlorhydrate de pramipexole monohydraté 1.0mg - nonergot-derivative dopamine receptor agonists
apo-pramipexole comprimé
apotex inc - dichlorhydrate de pramipexole monohydraté - comprimé - 1.5mg - dichlorhydrate de pramipexole monohydraté 1.5mg - nonergot-derivative dopamine receptor agonists
apo-pramipexole comprimé
apotex inc - dichlorhydrate de pramipexole monohydraté - comprimé - 0.125mg - dichlorhydrate de pramipexole monohydraté 0.125mg - nonergot-derivative dopamine receptor agonists
apo-pramipexole comprimé
apotex inc - dichlorhydrate de pramipexole monohydraté - comprimé - 0.75mg - dichlorhydrate de pramipexole monohydraté 0.75mg - nonergot-derivative dopamine receptor agonists
pms-pramipexole comprimé
pharmascience inc - dichlorhydrate de pramipexole monohydraté - comprimé - 0.25mg - dichlorhydrate de pramipexole monohydraté 0.25mg - nonergot-derivative dopamine receptor agonists